Researchers evaluated the 1-year safety data on subcutaneous levodopa/carbidopa continuous infusion with ND0612, an investigational subcutaneous delivery system providing minimally invasive continuous infusion, in patients with Parkinson disease.
Your search for major depressive disorder returned 189 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
In a study presented at MDS 2021, researchers assessed whether patients with tic disorders with or without major psychoses were at risk of developing tardive dyskinesia.
Patients with atrial fibrillation (AF) cite multiple reasons for nonadherence to direct-acting oral anticoagulant (DOAC) therapy.
Researchers compared the effects of 4 contemporary ablative neurosurgical procedures on treatment-resistant psychiatric symptoms.
Use of ketamine and esketamine for their antidepressant effects does not seem to have harmful neurocognitive effects in individuals with treatment-resistant depression.
This systematic review and meta-analysis of randomized controlled trials assessed the efficacy and safety of gabapentin and duloxetine for treating patients with painful diabetic peripheral neuropathy.
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
Acceptability of a passive smartphone-based ecological momentary assessment (EMA) app is relatively low among individuals with schizophrenia spectrum disorders.
This was a study protocol for a phase II pilot feasibility study that will assess the feasibility of ketamine for depression in patients with advanced life-limiting illnesses.
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Suicidal ideation, plan, and attempt in young U.S. adults increased from 2008-2009 to 2018-2019 after controlling for MDE, cannabis use, and CUD.
This retrospective study assessed the serum IgG antibody response to different MOG isoforms, as well as the value of using additional MOG isoforms on MOG-IgG in cell based assays.
Major depressive episodes reduce visual contrast suppression among patients with depressive disorders, a study shows.
This genome-wide associated study expanded on the gene-environment correlation for childhood maltreatment and causal relationship between childhood maltreatment and health.
People with epilepsy are more likely to experience psychiatric comorbidities, which can have a highly negative effect on their condition, their mental state, and their overall quality of life. What are some of the effects stress and depression can have on a patient’s epilepsy?
Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.
Investigators conducted a survey to assess the incidence of COVID-19 in patients with multiple sclerosis as well as the influence of their comorbidities and treatments on outcomes.
AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.
Researchers compared how patients experiencing a major depressive episode and control participants perceived contrast patterns.
For patients with MDD, the change in scores for depression at six weeks does not differ significantly with psilocybin or psilocybin plus escitalopram.
The researchers evaluated the various impacts of the concurrent COVID-19 and opioid epidemics, taking into consideration the severely restricted access to chronic pain management.
To evaluate whether patients with isolated dystonia are at an increased risk for suicidal behavior, researchers administered an anonymous electronic survey.
The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.
For people with dementia with symptoms of depression, without a MDD, nondrug interventions are more efficacious than drug interventions.
The phase 3 SPR1NT trial is an ongoing open-label, single-arm study evaluating onasemnogene in presymptomatic patients (≤6 weeks of age) with a genetic diagnosis of SMA and 2 or 3 copies of survival motor neuron 2 gene.
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
Researchers from Dalhousie University in Canada searched publication databases through September of 2020 for articles on ADHD, attention deficit disorder, bipolar disorder, and affective psychosis.
Study researchers investigated the optimal sleep strategies for cognition and their underlying mechanisms.
Study researchers sought to address the gap in research regarding the association between poor sleep and executive function in children with ASD, ADHD, or typical development